Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
2 drugs for “Cataract”
Phase 3 2
- Bimatoprost implant systemSpyGlass Pharma, Inc.Cataract
- Dextenza ophthalmic insertOCULAR THERAPEUTIX, INCCataract
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.